
The Global Economy’s Toughness Is Being Played By The Stunt Double
An imaginary action-film premiere celebrates a fearless star and keeps the cost of the padding out of the trailer.
Read More →
An imaginary action-film premiere celebrates a fearless star and keeps the cost of the padding out of the trailer.
Read More →
The patient and the shareholder have different definitions of a healthy drug price. The presidency has acquired an interest in both.
Read More →
The administration restricted green-card sponsorship by Microsoft and seven other companies. Now the tech industry is discovering that talent pipelines also need a functioning operating system.
Read More →
HHS sent the White House a plan that could ease access to compounded peptides despite unresolved safety questions. Federal drug policy is apparently testing a new evidentiary standard: extremely confident gym lighting.
Read More →
CoreWeave’s bonds slid into distress territory as investors reconsidered the debt beneath the AI buildout. Apparently infinite compute still comes with a monthly payment.
Read More →